MBB Public Markets I LLC Purchases New Position in Henry Schein, Inc. $HSIC

Key Points

• MBB Public Markets I LLC has acquired a new stake in Henry Schein, purchasing 4,500 shares valued at approximately $308,000 during the first quarter.
• Henry Schein reported earnings of $1.10 per share for the last quarter, falling short of analysts' expectations, while revenue increased by 3.3% year-over-year to $3.24 billion.
• The company's stock has seen recent analyst rating shifts, with five analysts giving a Buy rating and a consensus rating of "Hold" with an average target price of $76.67.

MBB Public Markets I LLC bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,500 shares of the company's stock, valued at approximately $308,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Great Lakes Advisors LLC bought a new position in shares of Henry Schein during the first quarter valued at about $4,477,000. Clearline Capital LP bought a new position in shares of Henry Schein during the first quarter valued at about $16,095,000. Jones Financial Companies Lllp grew its stake in shares of Henry Schein by 24,351.3% during the first quarter. Jones Financial Companies Lllp now owns 542,330 shares of the company's stock valued at $37,144,000 after buying an additional 540,112 shares during the last quarter. Teza Capital Management LLC bought a new position in shares of Henry Schein during the first quarter valued at about $260,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Henry Schein by 1.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company's stock valued at $1,155,000 after buying an additional 229 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HSIC. Leerink Partners set a $75.00 price objective on Henry Schein in a research note on Monday, July 14th. Robert W. Baird reiterated a "neutral" rating and set a $72.00 target price (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Barrington Research dropped their target price on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a report on Wednesday, August 6th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 target price for the company in a report on Tuesday, August 26th. Finally, Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Henry Schein presently has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Stock Down 0.1%

Shares of HSIC stock traded down $0.09 during trading hours on Tuesday, hitting $68.72. 261,656 shares of the company's stock traded hands, compared to its average volume of 1,733,914. The stock's fifty day simple moving average is $69.23 and its two-hundred day simple moving average is $69.42. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The stock has a market cap of $8.33 billion, a price-to-earnings ratio of 22.18, a PEG ratio of 2.28 and a beta of 0.86. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein's revenue was up 3.3% on a year-over-year basis. During the same period last year, the business earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.